ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Won Young Tak, Young-Oh Kweon, Soo Young Park, Seung Up Kim Clinical Gastroenterology and Hepatology.2023; 21(9): 2278. CrossRef
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Won Young Tak, Jun Yong Park, Young-Oh Kweon, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Soo Young Park, Seung Up Kim Clinical Gastroenterology and Hepatology.2022; 20(4): e794. CrossRef
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status Mi Na Kim, Seong Gyu Hwang, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Seung Up Kim, Sang Hoon Ahn Gut and Liver.2019; 13(2): 197. CrossRef
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G Gut and Liver.2017; 11(1): 129. CrossRef
KASL clinical practice guidelines: management of chronic hepatitis B
Clinical and Molecular Hepatology.2016; 22(1): 18. CrossRef
Hepatitis B Virus Infection in B-Cell Non-Hodgkin’s Lymphoma, and Effect of Entecavir in Prophylactic Antiviral Therapy Jinjing Chen, Haizhen Yi, Hong Cen, Wei Yan Health.2016; 08(05): 495. CrossRef
Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib Seungtaek Lim, Jungwoo Han, Gun Min Kim, Kwang‐Hyub Han, Hye Jin Choi Journal of Gastroenterology and Hepatology.2015; 30(6): 1024. CrossRef
Two Cases of Hypophosphatemic Osteomalacia After Long-term Low Dose Adefovir Therapy in Chronic Hepatitis B and Literature Review Hye Jin Jeong, Ji Min Lee, Tae Han Lee, Ji Yeon Lee, Han Byeol Kim, Mi Hwa Heo, Go Choi, Jin Nyeong Chae, Ji-Min Kim, Sang-Hyon Kim, Kun Young Kwon Journal of Bone Metabolism.2014; 21(1): 76. CrossRef
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy Hyun Jung Lee, Dae Young Kim, Bhumsuk Keam, Jeong Hoon Lee, Sae-Won Han, Do-Youn Oh, Jung Hwan Yoon, Tae-You Kim, Yu Jung Kim, Keun Wook Lee, Jin-Wook Kim, Sook-Hyang Jeong, Jong Seok Lee, Jee Hyun Kim, Seock-Ah Im Breast Cancer.2014; 21(4): 387. CrossRef
Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma Seung Up Kim, Kyu Sik Jung, Sarah Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Kwang‐Hyub Han, Young Nyun Park Liver International.2014; 34(7): 1008. CrossRef
A Case of Reactivation of Hepatitis B and Fulminant Hepatitis which developed 3 months following Chemotherapy Including Rituximab in a Patient with Lymphoma Tae Won Lim, Hee Taek Oh, Seung Un Song, Hae Won Lee, Ji Yeon Kim, Seon Ja Park Kosin Medical Journal.2014; 29(2): 161. CrossRef
Long‐term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea Yoon Hea Park, Beom Kyung Kim, Ja Kyung Kim, Hyeon Chang Kim, Do Young Kim, Jun Yong Park, Kwang‐Hyub Han, Seung Up Kim, Seung Hwan Shin, Kyu Yeon Hahn, Sang Hoon Ahn Journal of Gastroenterology and Hepatology.2014; 29(5): 1005. CrossRef
Adding adefovir vs. switching to entecavir for lamivudine‐resistant chronic hepatitis B (ACE study): a 2‐year follow‐up randomized controlled trial Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Chang Wook Kim, Chang Don Lee, Sang Hoon Park, Myung Seok Lee, Choong Kee Park, Hee Bok Chae, Moon Young Kim, Soon Koo Baik, Yun Soo Kim, Ju Hyun Kim, Jung Il Lee, Jin Woo Lee, Sun Pyo Hong, Soon Ho Um Liver International.2013; 33(2): 244. CrossRef
Comparison of chemiluminescence immunoassay (CIA) and immunochromatography assay(ICA) for Detecting HBsAg and Anti-HBs Hye-Jeong Kim, Eun-Hee Kim Journal of the Korea Academia-Industrial cooperation Society.2013; 14(7): 3419. CrossRef
Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park BMC Research Notes.2013;[Epub] CrossRef
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D Lucio Boglione, Antonio D'Avolio, Giuseppe Cariti, Gabriella Gregori, Elisa Burdino, Lorena Baietto, Jessica Cusato, Valeria Ghisetti, Francesco G. De Rosa, Giovanni Di Perri Liver International.2013; 33(4): 580. CrossRef
Assessment of the Quality of Clinical Practice Guidelines in Korea Using the AGREE Instrument Min-Woo Jo, Jin Yong Lee, Nam-Soon Kim, Soo-Young Kim, Seungsoo Sheen, Seon Ha Kim, Sang-il Lee Journal of Korean Medical Science.2013; 28(3): 357. CrossRef
Early on‐treatment change in liver stiffness predicts development of liver‐related events in chronic hepatitis B patients receiving antiviral therapy Beom K. Kim, Hyun J. Oh, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Kwang H. Han, Yehyun Park, Eun J. Yoo, Young N. Park, Seung U. Kim Liver International.2013; 33(2): 180. CrossRef
Trends in the seroprevalence of hepatitis B surface antigen in the South Korean population Seung Ha Park International Journal of Infectious Diseases.2012; 16(9): e669. CrossRef
Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg‐negative carriers Hana Park, Jung Min Lee, Ju Hee Seo, Hyon Suk Kim, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Chae Yoon Chon, Jun Yong Park Liver International.2012; 32(5): 796. CrossRef
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Clinical and Molecular Hepatology.2012; 18(2): 109. CrossRef
Simple Scoring System Predicting Genotypic Resistance During Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B Jeong-Hoon Lee, Jung-Hwan Yoon, Eun Ju Cho, Hyo Joon Yang, Eun Sun Jang, Min-Sun Kwak, Sang Youn Hwang, Su Jong Yu, Chang-Hoon Lee, Yoon Jun Kim, Chung Yong Kim, Hyo-Suk Lee Journal of Clinical Gastroenterology.2012; 46(3): 243. CrossRef
The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study Moon Seok Choi, Dong Hyun Sinn, Su-A Kim, Yil Seob Lee, Won Choi, Seung Woon Paik Gut and Liver.2012; 6(2): 241. CrossRef
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh Clinical and Molecular Hepatology.2012; 18(2): 195. CrossRef
Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy Yeo Myeong Kim, Sook-Hyang Jeong, Jin-Wook Kim, Sang Hyub Lee, Jin Hyuk Hwang, Young Soo Park, Nayoung Kim, Jong Seok Lee, Hyun Young Kim, Dong Ho Lee Journal of Clinical Virology.2011; 51(4): 241. CrossRef
Frequently used antiviral agents in the clinical environment Seunghoon Han, Dong-Seok Yim Journal of the Korean Medical Association.2011; 54(5): 530. CrossRef
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park The Korean Journal of Hepatology.2011; 17(3): 199. CrossRef
Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection J. W. Jang, S. H. Yoo, J. H. Kwon, C. R. You, S. Lee, J. H. Lee, K. W. Chung Alimentary Pharmacology & Therapeutics.2011; 34(11-12): 1337. CrossRef
Characterization of antiphospholipid antibodies in chronic hepatitis B infection Ji Young Huh, Dae Young Yi, Seong Gyu Hwang, Jin Jung Choi, Myung Seo Kang The Korean Journal of Hematology.2011; 46(1): 36. CrossRef
New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B Yoo-Kyung Cho, Byung-Cheol Song The Korean Journal of Gastroenterology.2011; 57(3): 144. CrossRef
Comparison of Clevudine and Entecavir for Treatment-naive Patients With Chronic Hepatitis B Virus Infection Eileen L. Yoon, Hyung Joon Yim, Hyun Jung Lee, Young Sun Lee, Jeong Han Kim, Eun Suk Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Soon Ho Um, Kwan Soo Byun Journal of Clinical Gastroenterology.2011; 45(10): 893. CrossRef
Genotypic resistance to entecavir in chronic hepatitis B patients Byeong Uk Kim, Ja Chung Goo, Byeong Chul Park, Soo Ok Kim, Sun Pyo Hong, Jee In Jeong, Hee Bok Chae, Seon Mee Park, Sei Jin Youn The Korean Journal of Hepatology.2010; 16(2): 147. CrossRef
A Case of Osteomalacia Related to Adefovir in a Patient with Chronic Hepatitis B Su Young Ahn, Soon Young Ko, Yun Mi Jang, Yong Hoon Choi, Byung Kook Kim, Won Hyeok Choe, Chang Hong Lee, So Young Kwon The Korean Journal of Gastroenterology.2010; 56(2): 117. CrossRef
Experience with Entecavir Therapy for Lamivudine-Resistant Chronic Hepatitis B in Korean Children and Adolescents Seung Man Cho, Byung-Ho Choe, Mi Ae Chu, Jung-Mi Kim Korean Journal of Pediatric Gastroenterology and Nutrition.2010; 13(1): 44. CrossRef
Management of Chronic Hepatitis B with Nucleoside or Nucleotide Analogues: A Review of Current Guidelines Moon Seok Choi, Byung Chul Yoo Gut and Liver.2010; 4(1): 15. CrossRef
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology Jae Keun Lee, Ju Hyun Shim, Han Chu Lee, Sae Hwan Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh Hepatology.2010; 51(5): 1577. CrossRef
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM Neung Hwa Park The Korean Journal of Hepatology.2009; 15(1): 106. CrossRef
Clinical efficacy of entecavir therapy and factors associated with treatment response in naïve chronic hepatitis B patients Myoung Hee Lee, Sun-Gyo Lim, Su Jin Jeon, Chang Joon Kang, Young Ju Cho, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho The Korean Journal of Hepatology.2009; 15(4): 446. CrossRef
Treatment of Hepatitis B Virus Resistant to Lamivudine and Adefovir Jin-Wook Kim The Korean Journal of Gastroenterology.2009; 53(5): 329. CrossRef
Antiviral Therapy for Chronic Hepatitis B Kwan Sik Lee Journal of the Korean Medical Association.2009; 52(8): 831. CrossRef
Clevudine therapy in patients with chronic hepatitis B Kwan Sik Lee The Korean Journal of Hepatology.2009; 15(2): 119. CrossRef
Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone† Ju Hyun Shim, Dong Jin Suh, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee Hepatology.2009; 50(4): 1064. CrossRef
Early development of clevudine resistance during clevudine therapy in a patient with chronic hepatitis B who received prior lamivudine therapy Yun Soo Kim, Geum‐Ha Kim, You‐Jin Hwang, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim Liver International.2009; 29(6): 950. CrossRef
